Calendar

«« Dec 2007 »»
S M T W T F S
           
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27 28 29
30 31

Search Box


HealthCentral Top Site Award

IBS Tales Hope Award

LinkBlog

'Managing Holiday Stress' a LifeCare® guide (PDF)

Generalized Anxiety Disorder - Patient treatment manual (pdf)

Understanding post-traumatic stress disorder

  More

Contact

Mailing List

RSS Feeds








Translation

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.

recommended links

Depression is Real's Down & Up Show
      Weekly audio-casts from the
      Depression Is Real Coalition

we support

Kiva.org - micro loans that change lives

Moving a Nation to Care : Post Traumatic Stress Disorder and America's Returning Troops, by Ilona Meagher

No Longer Lonely.com

"just don't smoke"


"Don't smoke, whatever you do, just don't smoke."
                        Yul Brynner

Hit Counter

Total: 1,094,135
since: 14 May 2006

Admin console

Log-In

My Blog    My Profile

Leave Message

Add as neighbors






Blogion.com

Blog Flux Directory



Blogarama - The Blogs Directory

blog search directory

BlogTagstic - Blog Directory

Find Blogs in the Blog Directory



LS Blogs

Top Health Sites





Health Blogs - Blog Top Sites

Webloogle Blog Directory

Bloggapedia - Find It!

Abstract: D-Cycloserine augmented exposure therapy for OCD

« H E » email
posted Thursday, 28 June 2007

Biol.Psychiatry;doi:10.1016/j.biopsych.2006.12.020

D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder

Kushner MG, Kim SW, Donahue C, Thuras P, Adson D, Kotlyar M, McCabe J, Peterson J, Foa EB.

Department of Psychiatry (MGK, SWK, CD, PT, DA, MK, JM, JP), University of Minnesota, Minneapolis, Minnesota; Department of Psychiatry (EBF), University of Pennsylvania, Philadelphia, Pennsylvania.

Background: D-cycloserine (DCS), a glutamatergic partial N-methyl-d-aspartate (NMDA) agonist, can facilitate extinction learning related to cued fear in animals and humans. We predicted that DCS would accelerate obsession-related distress reduction in patients with obsessive-compulsive disorder (OCD) undergoing extinction-based exposure therapy.

Methods: We administered DCS (125 mg) or placebo in a double-blind fashion to individuals with OCD approximately 2 hours before each exposure session.

Results: D-cycloserine decreased both the number of exposure sessions required to achieve clinical milestones and the rate of therapy dropout. After four exposure sessions, patients in the DCS group reported significantly greater decreases in obsession-related distress compared with the placebo group; however, after additional sessions, the placebo group tended to catch up.

Conclusions: D-cycloserine augmentation has the potential to increase the efficiency, palatability, and overall effectiveness of standard exposure therapy for OCD.

tags: d cycloserine  obsessive compulsive disorder  

links: digg this    del.icio.us    technorati    reddit